Low-dose CT (LDCT) screening for individuals with a family history of lung cancer was cost-effective using Taiwan-based parameters; future work should incorporate real-world program data and subgroup analyses.
|Articles|August 1, 1998
The American Journal of Managed Care
- August 1998
- Volume 4
- Issue 8
Formulary Limitations and the Elderly: Results from the Managed Care Outcomes Project
Advertisement
Articles in this issue
about 28 years ago
Identification and Assessment of High-Risk Seniorsabout 28 years ago
Outpatient Antidepressant Utilization in a Dutch Sick Fundabout 28 years ago
Inborn Errors of Metabolism: Medical and Administrative "Orphans"about 28 years ago
Generic Drug Product Equivalence: Current StatusAdvertisement
Related to this article
Dallas population health roundtable exposes prior authorization hurdles, ICD coding gaps, and copay barriers delaying care coordination.
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Speakers at ASN Kidney Week urge nephrologists to appeal prior authorization denials, include children in trials, and expand access to glomerular disease therapies globally.
ASN Kidney Week 2026 experts discussed GLP-1 RAs alongside lifestyle care, global access, and bariatric surgery for obesity in chronic kidney disease.
Full INTerpath-001 results show the individualized mRNA therapy plus pembrolizumab reduced recurrence risk in resected stage IIB-IV melanoma.
Kidney Week 2026 abstracts show that AMKD progresses quickly in routine practice, with or without diabetes, despite background CKD therapy.
Insurance barriers were the top reason 4 in 10 people prescribed long-acting PrEP at a Missouri clinic never received it, an IDWeek 2026 poster found.
Advertisement
Advertisement
Trending on AJMC
1
Merck, Moderna Cancer Vaccine Cuts Melanoma Recurrence Risk by 42%
2
Real-World AMKD Data Highlight Quick Progression, Unmet Needs
3
UPMC Health Plan's Food as Medicine Pilot for Members With Diabetes
4
Pulmonary Embolism Can Affect Elite Athletes, Too: Samantha Pettigrew, MD
5